Chloroquine-induced pruritus

Indian Journal of Pharmaceutical Sciences

Volumn 72, Issue 3, 2010, Pages 283-289

  Aghahowa, S E ^a   Obianwu, H O ^a   Isah, A O ^a   Arhewoh, I M ^a  

^a UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Chloroquine Induced pruritus; treatment

Indexed keywords

ACETYLGLYCERYLETHERPHOSPHORYLCHOLINE; AMMONIUM CHLORIDE; ANTIHISTAMINIC AGENT; CHLOROQUINE; CHLORPHENIRAMINE; CLEMASTINE; CORTICOSTEROID; DAPSONE; DESETHYL CHLOROQUINE; DIAZEPAM; DRUG METABOLITE; EXCIPIENT; HALOFANTRINE; HAPTEN; HYDROXYZINE; IMMUNOGLOBULIN E; KAPPA OPIATE RECEPTOR ANTAGONIST; KETOTIFEN; MEPYRAMINE; MONODESETHYLCHLOROQUINE; MU OPIATE RECEPTOR ANTAGONIST; NICOTINIC ACID; PHOSPHORYLCHOLINE; PLACEBO; PREDNISOLONE; PROMETHAZINE; SEROTONIN 3 ANTAGONIST; UNCLASSIFIED DRUG; VITAMIN B COMPLEX;

BLOOD GROUP ABO SYSTEM; CAUCASIAN; CLINICAL TRIAL; DERMOEPIDERMAL JUNCTION; DRUG EFFICACY; DRUG FORMULATION; DRUG IMPURITY; DRUG INDUCED DISEASE; DRUG METABOLISM; DRUG SAFETY; DRUG URINE LEVEL; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEREDITARY ATAXIA; HUMAN; MALARIA; MELANOCYTE; NEGRO; NERVE FIBER C; PARASITEMIA; PHARMACOGENETICS; PLASMODIUM; PLASMODIUM VIVAX MALARIA; PRURITUS; RACE DIFFERENCE; RETROSPECTIVE STUDY; REVIEW; SINGLE DRUG DOSE; SKIN PIGMENTATION; SPECIES DIFFERENCE;

EID: 77957746610     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.70471     Document Type: Review

References (34)

1. Bussaratid V, Walsh D, Wilairatana P, Krudsood S, Silachamroon U, Looareesuan S. Frequency of pruritus in plasmodium vivax malaria patients treated with chloroquine in Thailand. Trop Doct 2000;30:211-2.
2. Sowunmi A, Walker O, Salako L. Pruritus and antimalarial drugs in Africans. Lancet 1989;2:213-8.
3. George AO. Chloroquine pruritus: a possible fixed cutaneous reaction. Int J Dermatol 1996;35:323-4.
4. Osifo NG. Chloroquine Pharmacokinetics in tissue of pyrogen treated rats and implications for chloroquine related pruritus. Res Commun Chem Pathol Pharmacol 1980;30:419-30.
5. Skidgel RA, Eridos EG. Histamine, Bradykinin, and their Antagonists. In: Brunton LL, Lazo JS, Parker KL, editors, The Pharmacological Basis of Therapeutics. 11th ed. London: McGraw-Hill; 2001. p. 629-50.
6. Bodo E, Biro T, Telek A, Czifra G, Griger Z, Toth BI, et al. A hot new twist to hair biology: involvement of vanilloid receptor-1 (VR1/TRPV1) signaling in human hair growth control. Am J Pathol 2005;166:985-98.
7. Lazar J, Szabo T, Marincsak R, Kovacs L, Blumberg PM, Biro T. Sensitization of recombinant vanilloid receptor-1 by various neurotrophic factors. Life Sci 2004;75:153-63.
8. Schofield OM, Rees JL. Skin Disease. In: Nicolas AB, Nicki RC, Brian RW, John AA. editors. Davidson's Principle and Practices of Medicine. 20th ed. London: Churchill Livingstone; 2000. p. 1257-315.
9. Ademowo G, Walker O, Sodeinde O. Prevalence of Chloroquine-Induce Pruritus. Evidence for Heredo-Familial Factors. Malar Infect Dis Afr 1998;8:14-8.
10. Osifo NG. Chloroquine-induced pruritus among patients with malaria. Arch Dermatol 1984;120:80-2.
11. Ajayi AA, Oluokun A, Sofowora O, Akinyele A, Ajayi AT. Epidermiology of antimalaria induced pruritus in Africans. Euro J Clin Pharmacol 1989;37:539-40.
12. Ademowo OG, Sodeinde O. Certain red cell genetic factors and prevalence of chloroquine-induced pruritus. Afr J Med Med Sci 2002;31:341-3.
13. Davis S, Hegde S, Gogtay NJ, Dalvi SS, Mehta S, Kshirsagar NA. A patient of malaria with itching: Chloroquine induced pruritus. Clin Pharmacol 2004;1.
14. Osifo NG. Mechanisms of enhanced pruritogenicity of chloroquine among patients with malaria: a review. J Med Medical Sci 1989;18:121-9.
15. Buszman E, Kopera M, Wilczok T. Electron spin resonance studies of chloroquine-melanin complexes. Biochem Pharmacol 1984;33:7-11.
16. Ekpechi OL, Okoro AN. A pattern of Pruritus due to chloroquine. Arch Dermatol 1964;89:631-2.
17. Adebayo R, Sofowora G, Onayemi O, Udoh J, Ajayi A. Chloroquineinduced pruritus in malaria fever: contribution of malaria parasitaemia and the effects of prednisolone, niacin, and their combination, compared with antihistamine. Br J Clin Pharmacol 1997;44:157-61.
18. Asawalam B, Osifo N, Haller L. Drugs against chloroquine antimalarial Itch. J Eur Acad Dermatol Venereol 1993;2:193-9.
19. Fitzpatrick TB, Haynes HA. Pigmentation of the skin and disorders of melanin metabolism. In: Wintrobe MM, editor. Harrison's Principles of Internal Medicine. New York: McGraw-Hill; 1974. p. 273-81.
20. Sjolin-Forsberg G, Berne B, Blixt C, Johnsson M, Lindstrm B. Chloroquine phosphate: a long-term follow up of drug concentration in skin suction blister fluid and plasma after. Acta Derm Venerol 1993;73:426-9.
21. Jimbow K, Quevedo WC, Prota G, Fitzpatrick TB. Biology of melanocytes. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI, et al. editors. Dermatology in General Medicine. 5th ed. New York: McGraw-Hill; 1999. p 192-220.
22. Sjolin-Forsberg G, Berne B, Blixt C, Johnsson M, Olsson MJ. Rollman O. Differential uptake of chloroquine by human keratinnocytes and melanocytes in culture. Arch Dermatol Res 1996;288:211-15.
23. Olatunde IA. Chloroquine concentrations in the skin of rabbits and man. Br J Pharmacol 1971;43:334-40.
24. Sams WM Jr, Epstein JH. The affinity of melanin for chloroquine. J Invest Dermatol 1965;45:482-7.
25. Adebayo R, Sofowora G, Onayemi O, Udoh J, Ajayi A. Chloroquineinduced pruritus in malaria fever: contribution of malaria parasitaemia and the effects of prednisolone, niacin, and their combination, compared with antihistamine. Br J Clin Pharmacol 1997;44:157-61.
26. Bergqvist Y, Domeij-Nyberg B. Distribution of chloroquine and its metabolite-desethylchloroquine in human blood cells and its implication for the quantitative determination of these compounds in serum and plasma. J Chromatogr 1982;229:241-7.
27. Okor R. Responsiveness of chloroquine-induced pruritus to antihistamine therapy-a clinical survey. J Clin Pharm Ther 1990;15:147-50.
28. Okor R. Onset of pruritogenicity of chloroquine and the implication for the timing of suppressive therapy. J Clin Pharm Ther 1991;16:463-5.
29. Metze D, Reimann S, Beissert S, Luger T. Efficacy and safety of naltrexone, an oral opiate receptor antagonist, in the treatment of pruritus in internal and dermatological diseases. J Am Acad Dermatol 1999;41:533-9.
30. Heyer G, Groene D, Martus P. Efficacy of naltrexone on acetylcholineinduced allokinesis in atopic eczema. Exp Dermatol 2002;11:448-55.
31. Kamei J, Nagase H. Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice. Eur J Pharmacol 2001;418:141-5.
32. Crouzette J, Vicaut E, Palombo S, Girre C, Fournier PE. Experimental assessment of the protective activity of diazepam on the acute toxicity of chloroquine. J Toxicol Clin Toxicol 1983;20:271-9.
33. Abila B, Ikueze R. Effects of clemastine, ketotifen and prednisolone on chloroquine-induced pruritus. J Trop Med Hyg 1989;92:356-9.
34. Schwörer H, Ramadori G. Treatment of pruritus: a new indication for serotonin type 3 receptor antagonists. J Mol Med 1993;71:659-62.